Evaluating Capacity/Collaboration Building Efforts
Not as Easy as You Think!
The Gestational Diabetes Collaborative
National Association of Chronic Disease DirectorsProgram Integration Teleconference
September 12, 2011
National Collaborators CDC Division of Diabetes Translation CDC Division of Reproductive Health Association of Maternal and Child
Health Programs (AMCHP) National Association of Chronic
Disease Directors (NACDD) NACDD Women’s Health and Diabetes
Councils
What Is the Goal of This Project?
To foster integration (collaboration) of MCH and chronic disease programs in the development of diabetes prevention
initiatives
Objectives of this Project
Discover connections between maternal health and chronic disease prevention across the lifespan, especially for women of child-bearing age (15-44).
Articulate lessons learned from maternal and child health (MCH) and chronic disease initiatives that focus on diabetes prevention among women of child-bearing age.
Understand the maternal and infant complications associated with GDM and particularly, the increased risk of developing Type 2 diabetes among women with a history of GDM).
Objectives continued Share information about existing state data sources that can
monitor:◦prevalence of GDM◦prevalence of type 2 diabetes among women ages 15-44
years◦risk factors for GDM and type 2 diabetes such as obesity, inactivity, family history of diabetes, and previous birth of an infant >4000 grams.
Develop a state action plan to prevent or delay the development of Type II diabetes among women who have a history of GDM.
Identify and prioritize at least three possible strategies for MCH and chronic disease program collaboration to address critical issues in gestational diabetes data collection, diagnosis, treatment and follow-up
Objectives continued Engage in teambuilding to develop the plan for
action
Identify and address factors that promote or hinder MCH and chronic disease collaborations
List potential partners (internal and external) to assist in collaboration
Participate in a capacity assessment survey at baseline and 12 months later
Methods 1 ½ day workshop on collaboration Baseline and follow-up assessments
after 12 months Zoomerang assessments completed
independently by MCH and Chronic Disease Directors
States: Missouri, Ohio, West Virginia
Assessment Design Three Sections
I. MCH and CD Collaboration
II. GDM Competencies
III. Capacity for reducing Type 2 Diabetes among women with hx of GDM
Likert ScaleAssigned points to Scale:
1 = Strongly disagree2 = Disagree3 = Neutral4 = Agree5 = Strongly agree
I: Networking/Cooperation Participate on committees together Have constructive work relationships Are committed to the GDM
collaboration Seek opportunities to collaborate Support each others’ program’s efforts Keep appointments with one another
I. Coordination/Resource Sharing
Share data and information of mutual interest
Proactively coordinate on assignments of common interest
Regularly meet about programming
I. Policy Development, Planning, and
Decision-Making Invite participation of one another when developing
messaging, marketing, or packaging of promotional materials
Share accountability and credit for joint initiatives’ successes
Jointly plan analyses and publications Share resources to expand services Jointly develop funding applications Jointly develop policy around women’s health issues Make decisions together to further enhance women’s
health issues
II. Knowledge/Ability Association between GDM and development of
Type 2 diabetes Key overlapping chronic disease and MCH
issues related to GDM and diabetes prevention Evidence-based approaches to GDM
management, prevention and control Current scientific evidence for GDM/diabetes
prevention programs and practices GDM/diabetes prevention initiatives for
different populations
II. Data Identify appropriate data sources relevant to
GDM/diabetes prevention initiatives Use data to identify and monitor GDM and diabetes
burden, trends, and outcomes among women Use data to develop recommendations for changes
in policy, programs, data collection, and practice. Use data to develop and prioritize intervention
strategies for GDM/diabetes prevention initiatives Use MCH and Diabetes program evaluation findings
to improve GDM/diabetes prevention initiatives
III. Funding
Dedicated funding for GDM initiatives Funding for staff training related to
GDM initiatives Budget for medical supplies or
equipment related to GDM initiatives Budget for promoting GDM initiatives
III. Staffing Dedicated staff time for GDM program
integration efforts Commitment to GDM program integration efforts GDM programmatic knowledge, training, and
skills Adequate time to monitor program activities Ability to effectively build support with
management Access to program evaluation expert
consultation on GDM initiatives
III. Effective Leadership Leadership support for MCH and CD collaboration
and integration in general Leadership support for developing or enhancing
current GDM activities to prevent Type 2 Diabetes Adequate oversight/management of GDM integrated
efforts Mentoring/technical assistance for GDM integrated
efforts GDM Program integration is a priority for leadership Has a GDM master plan and effective communication
of that vision
III. Internal Administrative Systems
Integrated data collection and surveillance systems Compatible administrative system across their
programs Compatible information technology and computer
systems across programs Coordinated management systems across
programs Communication networks and tools facilitate
information sharing
Preliminary Results Overall, there was increased capacity
and collaboration for GDM work between baseline and at the 12-month follow-up
Next Steps Due to staff changes in one state, the
assessments were completed by different people at baseline and follow-up, necessitating interviews with each state team member for validation of results
After validation and further analysis, results will be published and available
Contact InformationJoan Ware, Consultant
National Assoc. of Chronic Disease Directors
801-277-2353